Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin
Gallo, R.C.; Whang-Peng, J.; Adamson, R.H.
Journal of the National Cancer Institute 46(4): 789-795
1971
ISSN/ISBN: 0027-8874 PMID: 4995657 Document Number: 36336
Document emailed within 1 workday
Related Documents
Horwitz, S.B.; Horwitz, M.S. 1973: Effects of camptothecin on the breakage and repair of DNA during the cell cycle Cancer Research 33(11): 2834-2836Kamiya, S. 1986: Synthesis of antitumor nitrosourea derivatives and chemical studies of their mechanism of action Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 104: 1-19
Pan, X-dao.; Liu, H-yan.; Sun, P-yang.; Zhu, C-gen.; Yang, J.; Yuan, K-hong.; Han, R. 2004: Synthesis and antitumor activity of 20-O-linked camptothecin ester derivatives Yao Xue Xue Bao 39(8): 591-597
Li, J.; Wang, S.-X. 2016: Synergistic enhancement of the antitumor activity of 5-fluorouracil by bornyl acetate in SGC-7901 human gastric cancer cells and the determination of the underlying mechanism of action Journal of Buon: Official Journal of the Balkan Union of Oncology 21(1): 108-117
Azuma, I. 1977: Antitumor activity and action mechanisms of BCG cell-wall skeleton and related substances Kekkaku: 52(10): 528-530
Asamura, M.; Yokoyama, M.; Kanamaru, R.; Kikuchi, H.; Gamoh, M.; Okuno, M.; Yi, C.D.; Wakui, A. 1989: In vivo antitumor activity of mitoxantrone and the flow cytometric analysis of its influence on cell cycle transition--comparison with doxorubicin and aclarubicin on ascitic hepatoma AH109A cells Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(12): 3769-3776
Li, K.; Yuan, D.; Yan, R.; Meng, L.; Zhang, Y.; Zhu, K. 2018: Stigmasterol exhibits potent antitumor effects in human gastric cancer cells mediated via inhibition of cell migration, cell cycle arrest, mitochondrial mediated apoptosis and inhibition of JAK/STAT signalling pathway Journal of BUON: Official Journal of the Balkan Union of Oncology 23(5): 1420-1425
Simpson, L.L.; Dasgupta, B.R. 1983: Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships Journal of Pharmacology and Experimental Therapeutics 224(1): 135-140
Chen, Y.; Wang, S.; Geng, B.; Yi, Z. 2018: Pelargonidin induces antitumor effects in human osteosarcoma cells via autophagy induction, loss of mitochondrial membrane potential, G2/M cell cycle arrest and downregulation of PI3K/AKT signalling pathway Journal of BUON: Official Journal of the Balkan Union of Oncology 23(3): 735-740
Hsiang, Y.H.; Lihou, M.G.; Liu, L.F. 1989: Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin Cancer Research 49(18): 5077-5082
Prasad, K.S.; Nayak, R.; Sirsi, M.; Ramakrishnan, T. 1976: Mechanism of action of antitumor antibiotic mithramycin Indian Journal of Cancer 13(4): 371-374
Eliassen, L.T.; Berge, G.; Sveinbjørnsson, B.; Svendsen, J.S.; Vorland, L.H.; Rekdal, Øy. 2002: Evidence for a direct antitumor mechanism of action of bovine lactoferricin Anticancer Research 22(5): 2703-2710
Sharykina, N.I.; Kudriavtseva, I.G.; Pavlovskaia, G.P. 2003: Mechanism of action of a novel antitumor preparation of chlofiden. Effect on RNA synthesis Ukrains'kyi Biokhimichnyi Zhurnal 75(1): 90-97
Pera, M.F.; Harder, H.C. 1979: Effects of mannitol or furosemide diuresis on cis-dichlorodiammineplatinum(II) antitumor activity and toxicity to host-renewing cell populations in rats Cancer Research 39(4): 1279-1286
Lauret, E.; Dumenil, D.; Miyanomae, T.; Sainteny, F. 1989: Further studies on the biological activities of the CFU-S inhibitory tetrapeptide AcSDKP. II. Unresponsiveness of isolated adult rat hepatocytes, 3T3, FDC-P2, and K562 cell lines to AcSDKP. Possible involvement of intermediary cell(s) in the mechanism of AcSDKP action Experimental Hematology 17(11): 1081-1085
Nakamura, T. 1980: Chemotherapy of acute leukemia from the viewpoint of the action mechanism of antitumor agents Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 43(6): 1022-1033
Tiuliandin, S.A.; Zhukov, N.V. 2009: Anti-VEGF therapy: clinical effectiveness, mechanism of antitumor action and resistance Voprosy Onkologii 55(3): 375-381
Torck, M.; Pinkas, M. 1996: Camptothecin and derivatives: a new class of antitumor agents Journal de Pharmacie de Belgique 51(4): 200-207
Roos, J.; Plas-Roser, S.; Hassani, M.; Aron, C. 1977: New data on luteotropic mechanism of action of estrogens during the rat estrus cycle Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 171(2): 446-450
Pan, X-dao.; Wang, C-ying. 2003: Current status of camptothecin derivatives as natural antitumor agents Yao Xue Xue Bao 38(9): 715-720